Veracyte® SEC Filings

Filing date	Form	Description	View
Jul 19, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001958244-23-001300.pdf 0001958244-23-001300.xls
Jul 19, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001384101-23-000132.pdf 0001384101-23-000132.xls
Jul 19, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001384101-23-000130.pdf 0001384101-23-000130.xls
Jul 18, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001958244-23-001296.pdf 0001958244-23-001296.xls
Jul 18, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001958244-23-001297.pdf 0001958244-23-001297.xls
Jul 17, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001958244-23-001292.pdf 0001958244-23-001292.xls
Jul 17, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001958244-23-001293.pdf
Jul 10, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-002207.pdf 0001950047-23-002207.xls
Jun 21, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001384101-23-000128.pdf 0001384101-23-000128.xls
Jun 15, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-001653.pdf

Data provided by Kaleidoscope.

Contact Information

Investors:

investors@veracyte.com
619.393.1545

Media:

Tracy Morris
tracy.morris@veracyte.com
650.380.4413

Disclaimer

The information in our press releases and webcasts should be considered accurate only as of the date of the press release or presentation. We disclaim any obligation to supplement or update the information in these press releases or presentations.